FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.264
+0.004 (1.42%)
At close: Dec 5, 2025, 4:00 PM EST
0.259
-0.005 (-1.78%)
After-hours: Dec 5, 2025, 7:55 PM EST
FibroBiologics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 16 | 70 | - | - | - | - |
| Enterprise Value | 18 | 64 | - | - | - | - |
| Last Close Price | 0.26 | 2.00 | - | - | - | - |
| PB Ratio | 101.85 | 25.66 | - | - | - | - |
| P/TBV Ratio | 129.30 | 25.66 | - | - | - | - |
| Debt / Equity Ratio | 56.90 | 3.86 | 1.39 | -1.88 | -1.18 | - |
| Quick Ratio | 0.72 | 1.10 | 1.00 | 0.32 | 0.23 | - |
| Current Ratio | 0.78 | 1.12 | 1.00 | 0.37 | 0.27 | - |
| Return on Equity (ROE) | -1292.87% | -559.73% | - | - | - | - |
| Return on Assets (ROA) | -115.62% | -60.75% | -66.75% | -105.51% | - | - |
| Return on Capital (ROIC) | -192.54% | -105.42% | -170.21% | -148.39% | -839.36% | - |
| Return on Capital Employed (ROCE) | -878.90% | -369.40% | -337.00% | 198.60% | 122.30% | - |
| Earnings Yield | -114.47% | -15.90% | - | - | - | - |
| FCF Yield | -103.11% | -17.22% | - | - | - | - |
| Buyback Yield / Dilution | -21.49% | -16.45% | - | -222.64% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.